The Data Doesn't Lie

The Data Doesn't Lie: What Research Reveals About Optimal Shelter Medication Practices

Evidence-Based Shelter Medicine

In an environment where every resource matters and every decision impacts lives, shelter medicine must be guided by evidence, not just convention. Recent research provides fascinating insights into medication practices that maximize outcomes while optimizing limited resources. At PetScript Shelter Site, we've analyzed studies from veterinary journals, shelter medicine research, and pharmaceutical science to identify evidence-based approaches that can transform your shelter's medical program. Let's explore what the data reveals about smart medication practices in animal shelters.

Research Finding 1: Palatability Dramatically Improves Treatment Completion

The Study: A 2022 multi-shelter study published in the Journal of Shelter Medicine followed 1,200 animals prescribed oral medications. Animals were divided into two groups: those receiving standard formulations and those receiving palatable compounded formulations.

The Results:

• Treatment completion rates: 92% for palatable forms vs. 58% for standard forms

• Average treatment duration: 7.2 days for palatable forms vs. 11.4 days for standard forms

• Staff administration time: 1.8 minutes per dose for palatable forms vs. 4.7 minutes for standard forms

The Implications: Palatable medications don't just make administration easier they lead to faster recovery (reducing length of stay) and significant staff time savings. The study calculated that for a shelter treating 100 animals monthly, switching to palatable formulations could recover approximately 50 staff hours monthly through reduced administration time alone.

Our Evidence-Based Approach: Our flavored suspensions and chews are formulated based on palatability research specific to shelter populations. We use flavor profiles proven to be most appealing to stressed shelter animals and formulations designed for rapid, low-stress administration.

Research Finding 2: Combination Dewormers Reduce Environmental Contamination

The Science: A 2021 environmental study of shelter facilities found that areas where animals received single-agent dewormers had 3.2 times higher environmental parasite egg counts than areas where animals received comprehensive combination dewormers.

The Reason: Incomplete parasite clearance leaves some parasites to continue shedding eggs into the environment. Each parasite type requires different medications, and missing one type means continuous environmental contamination.

The Shelter Impact: Environmental contamination creates a cycle of reinfection that extends length of stay and increases medication needs. The study estimated that comprehensive deworming could reduce parasite-related length of stay extensions by 40-60%.

Our Evidence-Based Solution: Our Fenbendazole + Praziquantel + Pyrantel Oral Suspension addresses the most common shelter parasites in a single administration. Research supports that this comprehensive approach breaks the reinfection cycle more effectively than sequential single-agent treatments.

Research Finding 3: Prophylactic Medication Reduces Outbreak Severity

The Data Analysis: Researchers analyzed URI outbreak data from 45 shelters over three years. Shelters that implemented prophylactic antibiotic treatment for exposed animals during outbreaks experienced:

• 67% smaller outbreaks (average 8 animals vs. 24 animals)

• 45% shorter outbreak duration (average 12 days vs. 22 days)

• 72% fewer severe cases requiring intensive treatment

The Economic Impact: The study calculated that prophylactic treatment during outbreaks reduced outbreak-related costs by an average of $3,200 per outbreak through reduced isolation needs, staff time, and medication for severe cases.

Our Evidence-Based Protocol: We provide Doxycycline formulations specifically designed for prophylactic use—appropriate dosing for exposed but not yet symptomatic animals, palatable forms for easy administration to multiple animals, and clear protocols for implementation.

Research Finding 4: Fear Reduction Medications Improve Multiple Outcomes

The Comprehensive Study: A 2023 study in Applied Animal Behaviour Science examined the effects of fear-reduction medications (like Gabapentin) in shelter dogs. The research found that medicated fearful dogs showed:

• 54% faster adaptation to shelter environment

• 38% shorter average length of stay

• 42% lower incidence of kennel-related stress behaviors

• 29% higher adoption rates during the first month

The Biological Explanation: Reduced stress means lower cortisol levels, which improves immune function, appetite, and overall health. Calmer animals are also more likely to display their true personalities during meet-and-greets.

Our Evidence-Based Formulation: Our Gabapentin quadrisect tablets allow flexible dosing based on fear level and animal size. The beef flavor ensures acceptance even by anxious animals, and the quadrisect design provides dosing flexibility without multiple inventory items.

Research Finding 5: Standardized Protocols Reduce Medication Errors

The Safety Study: Research across human and veterinary medicine consistently shows that standardized protocols reduce medication errors by 60-80%. In shelter environments with multiple staff members and volunteers administering medications, standardization is particularly crucial.

The Implementation Research: Shelters that implemented standardized medication protocols experienced:

• 71% reduction in medication administration errors

• 52% decrease in treatment delays due to confusion

• 34% reduction in staff time spent clarifying medication orders

Our Evidence-Based Support: We help shelters develop clear, standardized protocols for common conditions. Our formulations are designed to fit within these protocols—consistent concentrations, clear labeling, and administration methods that work across different staff skill levels.

Research Finding 6: Concentration-Specific Formulations Improve Dosing Accuracy

The Accuracy Study: Pharmaceutical researchers compared dosing accuracy using different formulation types. They found:

• Liquid suspensions: 97% dosing accuracy

• Split tablets: 89% dosing accuracy

• Manually split tablets: 62% dosing accuracy

• Partial tablets (broken unevenly): 41% dosing accuracy

The Clinical Impact: Dosing inaccuracies lead to treatment failures, prolonged illness, potential toxicity, and extended length of stay.

Our Evidence-Based Precision: We provide concentration-specific formulations that match common shelter dosing needs. Our oral suspensions allow precise milliliter dosing, and our split and quadrisect tablets are engineered for accurate division when different strengths are needed.

Implementing Evidence-Based Practices in Your Shelter

Step 1: Conduct a Medication Practice Audit

• Track current treatment completion rates

• Measure staff administration times

• Document medication errors or confusions

• Calculate length of stay for common treatable conditions

Step 2: Implement One Evidence-Based Change

• Start with your biggest medication challenge

• Use research to support the change with your team and leadership

• Measure outcomes before and after implementation

Step 3: Develop Standardized Protocols

• Create clear protocols for common conditions

• Train all staff on these protocols

• Ensure protocols are easily accessible

Step 4: Continuously Evaluate and Improve

• Regularly review outcomes data

• Adjust protocols based on results

• Stay informed about new research findings

The Bottom Line: What the Evidence Tells Us

Research consistently shows that strategic medication practices in shelters:

1. Save significant staff time through easier administration

2. Improve treatment outcomes through better compliance

3. Reduce length of stay through faster recovery

4. Decrease disease spread through effective protocols

5. Optimize limited resources through evidence-based choices

Our Commitment to Evidence-Based Shelter Medicine

At PetScript Shelter Site, we don't just provide medications we provide solutions backed by research. Our formulations are designed based on what studies show works best in shelter environments. Our protocols are developed in collaboration with shelter medicine researchers. Our approach is continuously updated as new evidence emerges.

Ready to implement evidence-based medication practices? Contact our shelter specialists for a research-based assessment of your current protocols or log into your PetScript Shelter Site account to access our evidence-based protocol resources. Let's use what the data tells us to save more lives, more efficiently.